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This thesis follows the research portfolio format and is carried out in part fulfilment of the 
academic component of the Doctorate in Clinical Psychology at the University of Edinburgh. 
An abstract provides an overview of the entire portfolio thesis. Chapter One contains a 
systematic review of published research investigatin  the experience of living with incurable 
forms of haematological malignancy. Chapter Two is an empirical study exploring adults’ 
experiences of living with follicular lymphoma while being maintained under the ‘watch and 
wait’ protocol. Both chapters are prepared for submission to the European Journal of Cancer 
Care, and follow their author guidelines.  
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Aims: Despite advances in cancer treatments, many types of haematological malignancy 
remain incurable. The aims of this research portfolio are: Firstly, to review the published 
qualitative literature pertaining to the experience of living with any form of incurable 
haematological malignancy; and secondly, to research the experience of living with a low-
grade malignancy, follicular lymphoma, while being maintained under observation without 
active treatment. 
Method: A systematic review and meta-synthesis of the literature was carried out. The 
methodology employed strict inclusion criteria and resulted in the identification of eight 
qualitative studies for inclusion in the review. For the research study, adults (n=9) diagnosed 
with follicular lymphoma were interviewed about their xperiences of living with the 
condition.  Interpretative Phenomenological Analysis was used to analyse the data. 
Results: The review highlighted the paucity of research in this area, with the majority 
focusing on people diagnosed with myeloma. However, th  quality of identified research 
was high, lending confidence to the conclusions of the reviewed studies. Themes identified 
from the collective body of literature were: The need for information; impact and meaning-
making; coping with an incurable condition; and adjustment and integration. The empirical 
study found an overarching theme of adjustment, encompassing three subthemes: Making 
sense of the condition in the context of existing ad evolving knowledge and experiences; 
intrapersonal and interpersonal coping strategies; and incorporating the condition into the 
life narrative. 
Conclusion: Patients with incurable haematological malignancies in general, and an indolent 
form of such malignancy in particular, have unique challenges to overcome in making sense 
of, coping with and integrating the condition into their life narrative and world view. There 
are subtle and easily missed barriers for understanding and coping with these conditions 
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The aim of this systematic review and meta-synthesis is to examine the experiences of 
people living with incurable haematological malignancies. Research in the area of 
psychosocial outcomes for haematology patients large y focus on high-grade, curable 
conditions, or the experience of specific symptoms r treatments. Some patients with 
incurable conditions will spend long periods of time being untreated for their condition and 
having relatively infrequent contact with healthcare services. These patients are also faced 
from diagnosis with the reality that they will die of or with their condition. By pooling the 
collective qualitative evidence in this area this review addresses the question of what it is 
like to live with these incurable conditions. Emerging from the synthesis and interpretation 
are complex needs for information; the impact and meaning-making that patients face; ways 
of coping with an incurable condition; and the processes of adjustment and integration 
patients experience. This provides breadth and a more cohesive picture of the current state of 
knowledge in this area, revealing gaps in the research that need to be addressed. 
 






Haematological malignancies are a highly complex group of disorders, including the 
leukaemias, lymphomas, and myeloma. While treatments have developed significantly in the 
last 30 years the majority of these cancers remain incurable. Although blood cancers are 
considered diseases of older people, they can affect younger adults and children. Incidence is 
increasing, and due to the aging population we can expect to see this trend continue. Due to 
the complexity of these conditions and ever evolving treatment approaches the outlook for 
patients is highly variable and uncertain (Lichtman, 2008).  
Lymphomas and leukaemias are commonly categorised as being either high- or low-
grade. High-grade disease is aggressive, may be rapidly fatal without treatment, but is treated 
with curative intent. Low-grade forms develop slowly and are often advanced by the time 
they are diagnosed. These conditions may be treated to slow progression but unless caught 
early are not currently considered curable. They ma, however, be survived for a decade or 
more, and are therefore a chronic illness.  In the indolent or low-grade forms of these 
diseases treatment is given to control symptoms and it is considered advisable to postpone 
treatment until the manifestation of clinical symptoms (Voliotis and Diehl, 2002). For low 
grade leukaemias and lymphomas median survival is around 10 years, with large variation 
from several months to a normal lifespan (Voliotis and Diehl, 2002). Leukaemia survival 
rates are around 44% at five years, placing them within the average range for cancers; while 
lymphomas have a relatively high five year survival rate of around 63% (Cancer Research 
UK, 2013). 
Myeloma is an incurable malignancy that has more sev re symptoms and a poorer 
prognosis than the low-grade haematological cancers. It has a relapsing remitting course, 
with has an asymptomatic indolent or ‘smouldering’ phase, and an active phase where 
treatment is given. Again, the aim of treatment is to control disease, prolong survival and 
maximise patient wellbeing (Sonneveld et al., 2013). Currently, myeloma is considered a 
life-shortening condition, with a median survival of approximately 33 months (Glass and 
Munker, 2007). The five-year relative survival rate is amongst the lowest of the 21 most 
common cancers at around 37%, with survival continuing to tail off after five years (Cancer 
Research UK, 2013).  
Regardless of underlying malignancy and prognosis, the preservation of quality of 
life is of major consideration in haematological malignancies (Voliotis and Diehl, 2002). 





with low grade haematological malignancies, despite their higher prevalence, are a 
significantly under-researched population (Parry, 2011). Johnsen et al. (2009) investigated 
the prevalence and predictors of symptoms and problems in a representative sample of 
haematological patients in Denmark. In a random sample of 470 patients with leukaemia, 
multiple myeloma and advanced lymphoma the most frequent symptoms or problems were 
fatigue (55%), reduced role function (49%), insomnia (46%), and pain (37%). Older patients 
and those in active treatment reported more symptoms and problems. 
A systematic review of unmet psychosocial needs in patients with haematological 
malignancies was presented at the International Psycho-Oncology Society World Congress 
of Psycho-Oncology (Swash et al., 2012). This found o ly 16 papers whose mixed cancer 
samples included haematology, and three papers whose participants had haematological 
malignancies only. The most significant difficulty for patients was identified as fear of 
recurrence. There were also unmet information needs, and needs relating to healthcare such 
as having confidence in healthcare professionals. 
Unlike patients with potentially curable high-grade malignancies, people with low-
grade malignancies or myeloma are faced from the outset with the reality that they will die 
of or with the condition. However, we have limited insight into what it is like for patients to 
live with such knowledge. It was suggested in a review of quality of life in patients with non-
Hodgkin’s lymphoma that qualitative research would enhance the understanding of the 
impact for survivors (Leak et al., 2011).  
This paper reports a systematic review and meta-synthesis of the qualitative 
literature in an attempt to ascertain the quality and quantity of the current knowledge base 
relating to patients’ experiences of living with incurable haematological malignancies. The 
aim is to answer the questions: What do we know that can help us understand and explain the 
experience of living with incurable haematological malignancies, what does this suggest for 
patient care, and what are the important questions for future research in this area? 
Method 
A systematic review and meta-synthesis of primary qualitative research was 
conducted, drawing on the method of framework analysis described by Jones (2004) and 






Search Strategy  
Searches of electronic databases were carried out between May and July 2013. The 
OVID databases Embase, Medline and PsycINFO were search d using key words, with 
Boolean operators where applicable, pertinent to qualitative research (‘qualitative research’ 
or ‘grounded theory’ or ‘phenomenology’) and haematological malignancies (‘lymphoma’ or 
‘non Hodgkin*’ or ‘haematological’ or ‘hematological’ or ‘leukaemia’ or ‘myeloma’). The 
same search terms were modified and applied to a search of CINAHL (‘qualitative’ or 
‘grounded theory’ or ‘phenomenolog*’ in the abstract) and (‘lymphoma’ or ‘non Hodgkin*’ 
or ‘haematolog*’ or ‘hematolog*’ or ‘leukaemia’ or ‘myeloma’ in the title). A search was 
conducted in Google Scholar (a search engine designd for locating scholarly articles) for the 
exact word or phrase, ‘qualitative research’; any of the words, ‘lymphoma’ or ‘ leukaemia’ or 
‘myeloma’; and none of the words, ‘acute’, ‘ children’, ‘ adolescents’, ‘ parents’, ‘ carers’, 
‘mothers’, and ‘fathers’). The final search strategies were arrived at after an initial ‘berry 
picking approach’ (Bates, 1989) and experimentation in all search platforms, using several 
combinations of specific and general search terms, as well as subject relevant filters, and 
guided by recommended search terms for locating qualitative research papers (Petticrew and 
Roberts, 2006). The reference sections of all retrieved articles were also hand-searched for 
potentially relevant titles.  
Inclusion Criteria 
The aim of this review was to examine the qualitative evidence pertaining to the 
experience of adults living with an incurable haematological malignancy. Studies were 
graded on the suitability of their sample characteristics in order to gain the greatest possible 
insight into these experiences. Attempts were made to avoid confusing the picture with the 
experiences of high-grade malignancies, since the natural histories, treatment approaches and 
prognoses for such conditions are different. However, this was not a simple task and a 
pragmatic approach was taken to inclusion and exclusion criteria. There is a paucity of 
research on psycho-social impact and experiences for individuals with haematological 
malignancies in general, with very few focusing on individuals with low-grade or incurable 
conditions. Studies were therefore included with mixed samples of individuals with different 
types of malignancy where it was considered that people with incurable conditions were 
reasonably well represented. A further consideration was how to capture the experience of 
living with these conditions. To achieve this aim, studies were excluded which explored the 
following: experiences of accessing, taking part in or recovering from specific treatments, 





holistic perspective in the review and because these areas have had more attention in the 
research already. Pre-diagnosis or end-of-life experiences were not included because these 
were deemed not to relate to the experience of knowingly living with an incurable form of 
cancer. Studies were included regardless of qualitative methodologies used, as this is argued 
to add to the depth and breadth of the description of the object of study (Jones, 2004) and 
because of the limited research having been carried out in this area.  
Publication Selection 
Qualitative papers’ titles can be uninformative; sometimes failing to indicate 
whether the research is qualitative (Jones, 2004) and as observed by Evans (2002) the 
relevance of qualitative research is often not clear from the title or abstract alone. Each title 
was therefore reviewed along with its abstract where the title alone was insufficient to judge 
the suitability of the paper. Full texts were obtained for potentially relevant papers. The 
search process yielded 509 papers, of which 24 wereretri ved in full. Full texts were 
examined in detail, and papers were rejected which fo used on treatment, intervention or 
symptom experiences, or where the sample was not repres ntative of people with incurable 
conditions, or where it was not possible to determine this. Ultimately, eight papers were 
deemed to be relevant to the review. These were graded s to the degree of relevance: (A) 
papers focusing specifically on the experience of living with a diagnosis of an incurable form 
of haematological malignancy (n=5); (B) those with mixed samples but reasonable clarity 
regarding the relative proportion of such patients, and an adequate representation of people 
with incurable malignancy (n=2); and (C) papers where the relative proportion of 
malignancy type was not made clear, but it was possible to determine through examining the 
text that a reasonable proportion of the sample was likely to have an incurable form of illness 
(n=1). Figure 1 represents the selection process diagrammatically. See Table 1 for a 






Assessment of Quality 
The studies were appraised for quality using an adapte  version of the quality 
assessment tool developed by Chivers-Seymour et al.(2010). This tool assesses 12 areas of 
the publication (covering the following areas: bstract and title; introduction and aims; 
method and data collection; sampling; data analysis; ethics, bias and rigour; clarity of 
results; transferability or generalisability; implications and usefulness; discussion of 
limitations; quality of quotes used; and relevance to review question) each area is rated on 
issues such as clarity, rigour and appropriateness of design based on clearly defined criteria, 
with a numerical score assigned for each rating: ‘good=3’, ‘fair=2’, ‘poor=1’, or ‘very 
poor=0’ (Appendix A). There was little difference in quality between studies, and ratings 
were high for all, ranging from 27-34 out of a possible 36, suggesting that there can be 
reasonable confidence in the research findings (summarised in Table 1, with a full 








from Google Scholar  
(n=314) 
Publications retrieved 
from reference sections 
(n=2) 
Rejected at  
title or abstract 
(n=130) 
Rejected at  
title or abstract 
(n=52) 
Rejected at  
title or abstract 
(n=313) 
Full papers retrieved 
(n=24) 
Rejected full papers (n=16) 
Insufficient evidence of experience relating to incurable 




A) All sample have incurable condition (n=5) 
B) Sample is mixed, but proportion is clearly defined 
and sufficiently balanced (n=2) 
C) Sample is not clearly defined, but sufficient evidence 
in text of adequate representation (n=1) 





Table 1. Summary of aims, method, sample details and quality ratings for reviewed articles 
Authors/ 
year Aim of study 
Sample  
properties Sampling 
Diagnosis – name of 
cancer and potential 
curability 





























All initially maintained 





















Mean age: 63 
 



















Mean age: N/S 
 
Purposive  Myeloma (incurable) N/S 
‘Not recently 
diagnosed’ 















Mean age: N/S 









Multiple myeloma: n=1 
(incurable) 
Non-hodgkin’s 
lymphoma: n=1 (N/S) 
 











Table 1. Continued 
Authors/ 
year Aim of study 
Sample  
properties Sampling 
Diagnosis – name of 
cancer and potential 
curability 



















Mean age: N/S 









Multiple myeloma: n=1 
(incurable) 
Non-hodgkin’s 
lymphoma: n=1 (N/S) 
Ewings sarcoma: n=1 
(potentially curable) 
 


















Mean age: 58 
 
Purposive  Myeloma (incurable) <1 year: n=4 
1–5 years: n=2 
















Mean age: 59 
Purposive  Curability N/S: 
Leukaemia: n=6 
Lymphoma: n=9 
State of illness: 
Stable (good 
prognosis): n=4 





















Mean age: N/S 
Convenience  Myeloma (incurable) 6 months– 
6 years 




N/S: signifies not specified in article 
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Data Extraction and Analysis 
The framework approach used in this review was adapte  from Chivers-Seymour et al. (2010): 
In order to reflect the participant’s voice in its purest form, data were extracted only from the ‘results’ 
section of each paper. The approach involved: (1) familiarisation through repeated reading of all 
papers, creating a list of themes and codes from the data; (2) identifying a thematic framework with 
final themes based on the key issues identified during familiarisation; (3) indexing, where the papers 
were coded manually, based on the thematic framework; (4) charting and mapping, where data were 
transferred to a matrix, charting themes against papers; and (5) interpretation, where coded data were
extracted from the matrix, clustered by theme, and explored for patterns and contradictions across the 
papers.  
Methodological Rigour in the Review Process 
In order to enhance the quality of this review an expert in qualitative research methodology at 
the University of Edinburgh was consulted at several points through the review process. In addition, 
three of the eight papers were reviewed by three ind pendent colleagues for assessment of the quality 
of these papers and to gauge the reliability of the author’s data coding, with 96% concordance between 
the author’s and colleagues’ coding. It would have be n desirable to have more than one author 
involved in the development of the thematic framework, however, this was not possible in the present 
study.  
Due to the nature of the population of interest, and in common with other meta-syntheses 
(Chivers-Seymour et al., 2010), there was heterogeneity in the study samples, and different qualitative 
approaches and styles used. While the quality of a review is influenced by the quality of the studies 
reviewed, these factors make it challenging to assess quality and pool data for meta-synthesis 
(Chivers-Seymour et al., 2010). Quality ratings were high for all articles and restricting analysis to 
data derived from the results sections of articles wa considered to be the most systematic approach fr 
pooling data. 
Results 
This meta-synthesis attempts to synthesise and understand the qualitative data relating to 
different aspect of the experience of living with incurable forms of haematological malignancy. The 
overarching impression was of patients attempting to negotiate a world in which mortality ceases to be 
an abstract concept and becomes a tangible reality. Participants gave accounts reflecting complex, 
varied and changing information needs; the impact of ancer and their efforts at making meaning of 
their diagnoses; attempts to cope with life with incurable conditions; and the process of adjustment 
and integration of the diagnosis into the self- andworld-view. Table 2 displays the studies from which 
the themes were derived. 
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Table 2. Emerging themes and studies they derive from 
Theme 1. The need for 
Information  
Theme 2. Impact and 
Meaning-Making 
Theme 3. Coping with an 
Incurable Condition 
Theme 4. Adjustment and 
Integration 
Evans et al. (2012) 
Kelly & Dowling (2011) 
Maher and De Vries (2011) 
Potrata et al. (2011) 
Randall and Wearn (2005) 
Vlossak and Fitch (2008) 
 
Evans et al. (2012) 
Kelly & Dowling (2011) 
Maher and De Vries (2011) 
McGrath (2004b) 
Potrata et al. (2011) 
Randall and Wearn (2005) 
Vlossak and Fitch (2008) 
 
Evans et al. (2012) 
Kelly & Dowling (2011) 
Maher and De Vries (2011) 
McGrath (2004a) 
McGrath (2004b) 
Potrata et al. (2011) 
Randall and Wearn (2005) 
Vlossak and Fitch (2008) 
Kelly & Dowling (2011) 
Maher and De Vries (2011) 
McGrath (2004a) 
McGrath (2004b) 
Randall and Wearn (2005) 
 
The Need for Information 
A common element of the patient experience was the idiosyncratic, complex and fluid 
requirements for information. There was variability between individuals and over time regarding how 
much information participants had wanted to receive; for example, one individual with low-grade 
disease had been frightened when information was withheld at the time of diagnosis in a misguided 
effort to protect her from anxiety (Evans et al., 201 ). Some participants had wanted to know very 
little about their condition at the time of diagnosis and appreciated not having information ‘forced’ on 
them (Randall and Wearn, 2005). However, a study exploring distressing experiences in myeloma 
patients found that, despite the relatively severe nature of this condition, all participants had wanted o 
know their diagnosis and to be told directly and as soon as possible (Potrata et al., 2011).  
Feeling able to trust healthcare professionals to provide accurate information was important 
for giving participants a sense of control over their situation and the uncertainty inherent in these 
conditions (Maher and De Vries, 2011). However, for s me participants there was a sense that the 
information they desired was not always forthcoming a d for some with low-grade cancer this was 
perceived as being due to the relative ‘disinterest’ of consultants in low-grade conditions. These 
participants also perceived there to be a general absence of information sources for people with 
haematological malignancies (Evans et al., 2012).  
The provision of information leaflets and written consultation summaries had helped some 
participants understand and maintain a sense of control over their information. However, many 
participants spoke of seeking information from sources other than their healthcare team. Participants 
across studies reflected on the frightening nature and potential inaccuracy of much of the information 
available to them. They spoke of finding ways to limit their exposure to worrying information, for 
example, by avoiding certain areas of the internet, or appointing a family member to ‘filter’ 
information for them.  
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Another important factor was the way that information s presented to patients. This was 
critical for helping patients feel comfortable and respected. For example, the use of technical language 
or long or complicated words was confusing and frightening for participants, leading them to feel 
uneasy about asking questions for fear of appearing ‘stupid’ or of being unable to understand the 
answer. A common experience was feeling that professionals were ‘too busy’ to provide the time and 
level of input required. Consultations during which patients receive ‘bad news’ are particularly 
stressful, and several participants spoke of having d fficulty finding the words to express their feelings 
or to formulate questions. Some participants also spoke of concealing their emotions from 
professionals in order to appear courageous (Maher nd De Vries, 2011). This may limit the mutual 
understanding between patients and their healthcare te m.  
Knowing how to use the information they had gained was a further challenge for patients. This 
is reflected in participants’ accounts around decision-making regarding their healthcare. In a mixed-
sample study many had little desire to contribute to treatment decision-making, feeling unqualified to 
make such choices (Randall and Wearn, 2005). For partici nts with myeloma, treatment often 
commences immediately after diagnosis, leaving patients feeling they had little time to consider their 
options. Some participants saw themselves as having little choice regarding their treatment due to the 
relative severity of this condition (Vlossak and Fitch, 2008). 
Impact and Meaning-Making 
Participants’ meaning-making involved combining existing knowledge, assumptions, and 
attributions regarding ‘cancer’ with newly acquired information regarding their diagnosis. However, 
haematological malignancies are a complex collection of conditions with variable courses and 
outcomes, and many participants struggled to make sense of their diagnosis. For example, some 
people who received a diagnosis of myeloma did not initially realise that it was a type of cancer (Kelly 
and Dowling, 2011). For individuals with low-grade isease even the provision of information did not 
always help them understand their diagnosis (Evans et al., 2012) and many made assumptions and 
created ‘worst case scenarios’ during their diagnosis, sometimes leading them to negatively 
misinterpret information. Some also had difficulty coming to terms with the indolent nature of the 
disease and of not having received treatment. Some individuals with incurable conditions also 
wondered what it would mean when their time came for treatment, and whether this signified the 
‘beginning of the end’. 
A common experience for those who had experienced symptoms was the wide-ranging impact 
these had, including a loss of independence, leaving participants feeling like a burden, useless and 
inadequate, but also resentful of those around them. Changes in appearance resulting from illness also 
affected how participants’ thought about themselves and how others viewed them, and the realisation 
that they could no longer conceal their cancer had a major psychosocial impact for some (Kelly and 
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Dowling, 2011). While all patients with haematological malignancies can experience debilitating and 
distressing symptoms, these findings are particularly significant for people with myeloma, who are 
more likely to experience symptoms which also tend to be more severe and visible. These patients 
talked of multiple losses as a result of their illness: of their former self, their identity, sense of value, 
friendships and the ability to participate in life, sometimes leading to depression, anxiety and social 
isolation (Maher and De Vries, 2011). 
Across studies, participants spoke of the difficulty they and their healthcare team could have 
in identifying whether symptoms they experienced could be attributed to their conditions. This 
appeared to be particularly significant for patients with low-grade disease, whose symptoms may be 
milder and more vague (Evans et al., 2012). A common experience was the ‘rollercoaster’ of emotions 
around routine checkups with preceding anxiety being replaced by intense relief if the condition had 
not progressed. 
Patients without symptoms had other issues to contend with: some found it confusing that they 
had begun to think of themselves as ‘ill’ while feeling well (Evans et al., 2012). For patients with low-
grade disease, particularly those who had comorbid health conditions, the condition could be 
perceived as insignificant, preventing participants sharing their diagnosis with loved ones (Evans et 
al., 2012). While participants were aware of stigma associated with cancer, one study with a mixed 
sample found that the word ‘cancer’ was seen by participants as preferable to ‘disease’. They also 
preferred ‘illness’, ‘condition’, or the proper medical name for their condition (Randall and Wearn, 
2005). This may be particularly significant for patients with asymptomatic low-grade disease who may 
not identify with the concept of being ‘diseased’. 
Participants’ accounts across several studies reflect d their attempts to understand how they 
had come to have their condition. There was a sense for some people that it was ‘fated to be’, or to be 
due to their own actions, while some ascribed a spiritual purpose to their condition, such as being 
‘tested’. Many participants, even individuals with myeloma, talked about a sense of being lucky in 
some way: to be alive, that treatment options were available to treat symptoms, or in their perceptions 
of their own situation in relation to others’. 
Coping with an Incurable Condition  
A variety of coping strategies were reported across studies: Some individuals spoke of the 
importance of maintaining hope, and how this could be damaged when participants perceived that 
clinicians did not believe in their ability to fight their illness. Randall and Wearn’s (2005) participants 
with incurable conditions found it harder to come to terms with treatment, for whom it is non-curative, 
than participants with curable conditions. It was still helpful for these patients to be offered some form 
of reassurance about what the future might hold. The hope of curative treatments becoming available 
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in the future was mentioned by some participants. Some also spoke of the importance of maintaining a 
sense of normality, despite having a lifelong condition, but this was hampered for some by family and 
friends being overprotective. Belief in an afterlife provided comfort for some but there was also a 
sense of participants being aware of their powerlessn s in the face of an incurable illness, and so 
avoiding the ‘long view’ when it came to coping, with some avoiding thinking about their condition 
altogether. 
Factors relating to individuals’ support networks were central to participants’ attempts to cope 
with their condition. They derived strength and comf rt from family and extended social networks, 
particularly for some with myeloma who spoke of how heavily they relied on others due to their 
symptom burden. However, the diagnosis of cancer can interfere with the life of every member of the 
family, and some family members coped through avoidance. It appears from this body of research that 
friends might play a greater role for cancer patients than is generally recognized, providing emotional, 
practical, and financial support. However some participants experienced dissolution of relationships 
with family or friends who had not been able or willing to be supportive. 
Participants described withholding information and hi ing their feelings to protect family and 
friends from distress or themselves from the stress of having to repeat their ‘story’. Patients with low-
grade leukaemia spoke of their condition being ‘invisible’, finding that sympathy (or even recognition) 
could be hard to obtain (Evans et al., 2012). This reflected a broader sense among study participants 
that their experiences could not be understood by members of their social network. Because of this, 
expressions of concern were sometimes perceived as disingenuous, as well as coming as unbidden 
reminders of conditions that some were trying to ‘forget’. Some participants spoke about the benefits 
of talking to other patients with the same condition, but for many who took part in these studies this 
option had not been available or sufficiently accessible. 
Patients with incurable conditions will remain engaged with healthcare teams for the rest of 
their lives and the importance of the patient-doctor relationship was apparent in participants’ accounts. 
The relationship was felt to be particularly important for these participants who perceive their 
conditions to be different to other cancers in showing no visible signs of progression. It was vital to 
them to know they would be seen regularly and kept informed about their condition (Randall and 
Wearn, 2005).The ability of the consultant to indivi ualize their patient’s experience was fundamental 
to the relationship. Continuity of care was perceived to allow clinicians to develop an understanding of 
patients’ idiosyncratic needs for information and how best to communicate this to them (Randall and 
Wearn, 2005). However, for patients with low-grade leukaemia there was a perception that even their 
doctors did not always appreciate how patients felt and how the condition could affect their lives 
(Evans et al., 2012)  
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The literature indicates that patients feel it is important to be made aware of the possible 
psychological impact of their condition (Randall and Wearn, 2005). There was a perceived absence of 
support groups for people with haematological conditions, or difficulty accessing them due to the need 
to travel. There may be barriers to patients accepting one-to-one counselling due to this being seen as 
‘dwelling on their condition’, or because of it being offered too soon after diagnosis for the patients to 
be ready to consider the offer. 
Adjustment and Integration 
Adjustment was found to be a challenging, fluid process occurring over a period of time, and 
involving participants recognising the limitations posed by their illness and managing their lives 
accordingly. Support, particularly from family members, was a vital component in promoting 
adjustment (Maher and De Vries, 2011). There is a confrontation with death experienced by those 
diagnosed with an incurable condition that makes one acutely aware of the fragility of life and one’s 
own mortality, with the consequence that patients are challenged to think closely about the meaning 
and purpose of their life.  
Many participants’ had a sense of having been given ‘the gift of extra life’, and of being more 
conscious of making the most of life. Many had re-examined their priorities and re-evaluated their 
lives, making changes that allowed them to focus on what was important. Personal relationships were 
explored, strengthened and deepened and some participan s spoke of an enhanced ‘sense of 
personhood’ (McGrath, 2004a) with increased assertiveness and co fidence, greater ability to focus on 
one’s own needs, with less feeling of responsibility for others and dependence on others’ approval. 
Some felt that their illness experiences had given th m insights and skills that were relevant and 
transferable to their daily life. 
It was recognised by participants that, due to the nature of their conditions, their illness 
journey would extend for their full lives, with some reporting that they had examined their past and 
managed to come to a position of peace with their future. This reflected a sense of acceptance of 
mortality with some patients even having a sense that they were ‘fortunate’ to have experienced the 
spiritual aspects of the illness journey. However, it was noted that the experience of distressing 
physical symptoms impacted on the ability of participants to take a broad and positive perspective on 
their situation or to derive a sense of spiritual growth from their experiences. 
Discussion 
As far as it has been possible to determine, this is the first systematic review and meta-
synthesis of qualitative research exploring the livd experiences of people with incurable 
haematological malignancies. The reviewed studies represent a range of stages and experiences along 
the patient journey, with patients diagnosed between four days and 18 years previously. Studies 
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focused on: receiving the diagnosis of haematological malignancy (Randall and Wearn, 2005); 
spirituality in patients’ meaning-making and positive llness experiences (McGrath, 2004a; 2004b); the 
experience of living with a low-grade leukaemia in which patients had to come to terms with a lack of 
immediate treatment and living with symptoms of an ‘invisible’ condition (Evans et al., 2012). Half of
the reviewed studies related to experiences of living with myeloma: Vlossak and Fitch (2008) found 
the most difficult obstacle for patients and family members to be the sudden confrontation with 
mortality; Kelly and Dowling (2011) emphasised the ‘preciousness of time’ for patients living ‘in 
limbo’ in a changed body; Potrata et al. (2011) found that distress in myeloma related to the 
experience of symptoms and the meaning patients made of them; and Maher and De Vries (2011) 
found patients with relapsed myeloma trying to cope with the uncertainty of an ‘ever-changing’ 
perspective between illness and wellness. 
Adjustment to serious illness refers to psychological processes occurring over time as the 
individual, and those in their social world, manage, learn from and adapt to the changes they have 
gone through (Brennan, 2001). Adjustment, therefore, is an ongoing process that does not equate to 
the absence of psychopathology and does not represent the end-point of the coping process. The 
concept of ‘liminality’ can be used as a framework for understanding cancer experiences, referring to a 
transition between two states, where people become ‘structurally invisible’, being ‘no longer 
classified, and not yet classified’ (Blows et al., 2012). Patients across studies are involved in a delicat  
balancing act of seeking the information they need in order to understand their situation while 
protecting themselves from becoming overwhelmed. Participants use new information and existing 
beliefs to make sense of their situations and for all participants the role of both personal and 
professional support networks were crucial for helping or hindering them in their illness journey. 
Patients with low-grade conditions appeared to juggle two conflicting ideas: Cancer as terrifying, 
deadly, and stigmatising, against a condition that goes largely unnoticed, unacknowledged and 
untreated. For participants with myeloma, with its more severe symptoms and poorer prognosis, the 
increased sense of fear and threat was palpable in th  body of research. Despite these differences there
was a general overall picture of participants strugglin  with the uncertainty of their future, fear of 
recurrence, and fear of the unknown.  
According to ‘crisis theory’ (Moos and Schaefer, 1986) people faced with major life crises and 
transitions experience disruption to their established personal and social identities and in order to cope 
with these challenges, psychological systems are driv n towards maintaining equilibrium. In the 
present review, universal coping strategies emerged with patients attempting to maintain hope and a 
sense of normality, while balancing defiance towards their condition with acceptance of an incurable 
diagnosis. Acceptance of their diagnosis appeared to allow participants to place the condition within 
the broader life story and to use this as a platform for becoming more in tune with their values and 
priorities. Ciarrochi et al. (2011) identified that greater success at ‘living one’s values’ was 
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significantly related to improved wellbeing and distre s-related outcomes for cancer patients. 
However, according to this review such positive growth may be stalled or blocked by distressing 
symptoms. 
Implications for Clinicians and Healthcare Teams 
The key findings of this review are that: (1) Information and support needs are idiosyncratic 
and change over time; (2) patients may have unarticula ed assumptions about cancer affecting their 
ability to understand and cope with their diagnosis f an incurable cancer; (3) patients may not express 
their thoughts and feelings about their situation to ei her social or professional support networks; and 
(4) ambivalence, poor timing of support offers, and barriers to accessing support services may prevent 
patients obtaining support and information that would help them understand and cope with their 
condition. 
These findings suggest that clinicians need to negotiate and re-visit information requirements 
for every patient throughout their cancer journey. Schapira and Tulsky (2008) provide a guide to help 
oncologists deal with the complex communication needs of cancer patients.  
Participants’ accounts reflected difficulty coping with the ongoing nature of their conditions as 
well as, for some, fear regarding end-of-life experiences. Patients’ beliefs should be openly explored, 
allowing the healthcare team to understand and address the individual psychological challenges faced 
by patients and helping them to address these.  
Maguire et al. (1996) suggest that patients can be helped to disclose their concerns by being 
allowed time to express their feelings, by showing them empathy, using open questions, asking about 
psychosocial issues, seeking clarification of any ps chosocially significant comments or non-verbal 
communications, summarising what they have said and offering ‘educated guesses’ as to how they 
might be feeling. For medical professionals this might result simply in the patient feeling heard and 
understood, in frank discussions about palliative care, or referrals to specialist psycho-social support 
services.  
Joined-up working within multidisciplinary teams will be crucial for helping patients to 
understand and cope with their illness experiences. With patients reporting that they conceal their 
feelings from healthcare professionals and social support networks it is important that systems are in 
place for monitoring adjustment and distress in patients, with opportunities for support offered 
repeatedly throughout the patient journey. It is hoped that developing a plain language summary of 
this review will provide patients and healthcare professionals with information that can help to 
normalise and validate the patient experience as well as inviting discussion of individual experiences 





As noted by Chivers-Seymour et al. (2010) the final selection of studies for meta-synthesis can 
represent a biased sample. In the present review, two papers referred to the results of one study, and of 
the papers purely relating to experiences of incurable conditions, four relate to the experience of 
multiple myeloma, and only one to an indolent condition (chronic lymphocytic leuakaemia).  
The haematological malignancies represent a diverse coll ction of diseases, and the distinction 
between low- and high-grade disease is not clear cut. Despite this, patients are generally categorised as 
having either a more slowly developing disease, which is unlikely to be curable, or a quickly 
developing disease that may be curable with the right treatment. Due to the limited research in this 
area three studies were included in this review that referred to samples with both high- and low-grade 
conditions. While examination of the sample characteristics suggests reasonable representation of 
people with incurable conditions this was not made explicit in the articles. Indeed, McGrath (2004b) 
refers to the significance of survival at five years for their participants in considering themselves 
‘cured’. This highlights the issue of combining diagnoses within samples making it difficult to draw 
conclusions about the unique experiences of those who have been told they are living with an 
incurable condition, as opposed to those who believ a cure is possible.  
Future Directions for Psychological Research 
This review emphasised the scarcity of research that has been carried out into patient 
experiences in the area of haematological malignancies. In particular, there has so far been only one 
study exploring the experiences of people living with a low-grade incurable haematological 
malignancy, despite the unique and potentially challenging existential issues faced by this population. 
Therefore, there is a need for more knowledge regarding the psychosocial experiences of patients 
living with indolent disease. 
The use of language around cancer continues to use the ‘military metaphor’ of fighting and 
losing battles with cancer. Potential problems with this were discussed in a seminal text by Susan 
Sontag (1978) which proposed the danger of framing the experience of cancer as a battle in which 
there are winners and losers, with ‘good’ patients fighting their disease to the death. This use of 
language may be particularly unhelpful for patients with incurable disease. Patients in this review also 
expressed discomfort with the word ‘disease’ being used to describe their condition and it may be 
beneficial to further explore the impact on patients of the language used around long-term incurable 
cancers. 
Considering the issue of ‘fighting against’ curable cancer versus ‘accepting and living with’ 
incurable cancer, there is potential utility in psychotherapeutic approaches aimed at supporting 
individuals’ acceptance while supporting their value-congruent living. Acceptance and Commitment 
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Therapy (Hayes et al., 1999) is a psychotherapeutic approach with a focus on helping patients accept 
distressing physical or psychological experiences in the service of ‘valued’ living. Research has begun 
to provide evidence for its effectiveness for peopl with cancer (Páez et al., 2007; Branstetter et al., 
2004; Feros et al., 2013), but it has not been trialled with patients with indolent cancers for whom it 
may particularly appropriate, given their incurable status, ongoing investigations and treatment 
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A study is reported that used the qualitative approach of interpretative phenomenological analysis 
(IPA) to explore the experiences of participants (n=9) living with a low-grade form of incurable 
haematological malignancy: follicular lymphoma. Participants’ accounts reveal an overarching theme 
of adjustment, comprised of making sense of the conditi  in the context of existing and evolving 
knowledge and experiences; intrapersonal and interpersonal coping strategies; and integrating the 
condition into the life narrative. Findings reinforce the importance of patients’ relationship with 
healthcare providers, and holistic, individualised care. The diagnosis can have subtle and far-reaching 
implications for social networks and the patient’s sense of self. Patients are involved in an intricate 
task of maintaining and relinquishing control, balancing their needs for support and self-reliance, and 
managing their concerns about illness with their enhanced sense of the preciousness of life. 
Suggestions are made for how healthcare teams can understand and respond to the unique needs of 
each patient.  
 




Lymphomas and leukaemias are types of haematologica malignancies that are commonly 
categorised as being either high- or low-grade. High-grade disease is aggressive, may be rapidly fatal 
without treatment, but is treated with curative intent. Low-grade forms develop slowly and are often 
advanced by the time they are diagnosed. These conditions may be treated to slow progression but 
unless caught early are not currently considered curable. They may, however, be survived for a decade 
or more, and are therefore a chronic illness.  Myeloma is another form of haematological malignancy, 
which is incurable and has a relapsing remitting course, but has more severe symptoms and a poorer 
prognosis than the chronic haematological cancers. 
Patients with low-grade malignancy are commonly maintained under a ‘watch and wait’ 
protocol, whereby they undergo regular routine examin tions to monitor for progression of their 
disease. If symptoms increase or there are other signs of progression, treatment may be given with the 
intention of reducing the disease. Once a treatment has been given it becomes ineffective and 
alternatives must be used at later treatments. Patients may be treated initially at diagnosis or may not 
receive their first treatment for several years. The average time from diagnosis to treatment is two to 
three years, with similar lengths of time between tr atments. However, intervals between treatments 
are likely to decrease over time.  
Time spent waiting at any point of cancer diagnosis and treatment is often emphasised as 
being highly stressful (Saegrov and Halding, 2004). It has been argued that cancer patients have a 
critical ‘need for action’ (Jakobsson et al., 2005), which patients under watch and wait may not feel is 
happening. These patients also have less contact with professionals than individuals with high-grade 
disease, perhaps missing out on support that may aid adjustment to the diagnosis (Horn and Campbell, 
2010).  
Haematological malignancies are under-researched in the psychological literature, with the 
majority of research that does exist focusing on aggressive diseases and their treatment. There is little 
known about psychological outcomes for patients with low-grade disease. Chronic lymphocytic 
leukaemia (CLL) is one of the most common lymphoid malignancies. A survey comparing the quality 
of life (QoL) of CLL patients to the general population found that while the physical, social/family, 
functional, and overall QoL scores of CLL patients were similar to or better than population norms, 
their emotional well-being was dramatically lower than that of both the general population and 
patients with other types of cancer, with younger patients having lower wellbeing (Shanafelt et al., 
2007). 
A recent review of QoL outcomes in people with non-Hodgkin’s lymphoma (NHL) which can 
be high- or low-grade, found that people with NHL had higher levels of posttraumatic stress 
symptomatology than population norms, but comparable levels of mental health functioning, although 
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this was poorer in younger patients (Leak et al., 2011). The review authors highlighted that qualitative 
methods would more adequately capture the totality of a survivor’s experience compared with using 
one QOL measure.  
Patients with prostate cancer are commonly maintained under watchful waiting, and 
significantly more research, including use of qualitative methodologies, has been carried out with this 
group. For example, Hedestig et al. (2003) found prostate patients experienced solitariness and 
uncertainty, and tended to avoid burdening friends and family by not talking about their condition, 
reducing their sources of support. These patients preferred to talk to other patients or healthcare 
professionals. 
A systematic review of qualitative literature pertaining to all forms of incurable 
haematological malignancy (Caldwell, 2013) identified only one study exploring the experiences of 
patients living with a chronic haematological malignancy: Evans et al. (2012) interviewed 12 patients 
under ‘watchful waiting’ for CLL. Their participants reported finding it difficult to come to terms with 
a condition which is incurable, but for which no treatment is recommended in its early stages. In 
common with the men with prostate cancer, the invisbility of CLL made some participants selective 
about whom they told, limiting the social support available to them. An email was circulated to 
members of the Special Interest Group in Oncology and Palliative Care (SIGOPAC, UK) community 
to ascertain whether any members were aware of qualitative research having been conducted with 
individuals with lymphoma living under watch and wait – this yielded no further research, although 
interest was expressed in the area. 
Follicular lymphoma (FL) is the most commonly occurring low-grade lymphoma. Compared 
with CLL, patients with FL are likely to be younger, to receive more frequent check-ups, and to 
ultimately require treatment (XXX  Chair of XXX  Cancer Network Haematology Group, personal 
communication, July 2012).  Because of the different cli ical characteristics, individuals with FL may 
have different experiences of watch and wait compared to those with CLL. No research to date has 
explored the experiences of individuals with follicu ar lymphoma who are not undergoing active 
treatment. We therefore have little knowledge about the support needs of this patient group during the 
majority of their life-long cancer journey.  
The present study aims to explore the lived experience of patients maintained under the watch 
and wait protocol for follicular lymphoma, in order to improve our understanding of the particular 
challenges and needs of this group of patients. Due to the limited research in this area, a qualitative 
approach (interpretative phenomenological analysis) will be used to explore how participants perceive 
and make sense of the world around them, and the meanings they construct regarding their personal 





Purposive sampling was used to recruit a relatively homogenous group of individuals who 
were able to reflect upon the phenomenon of interes (Smith and Osborn, 2003), i.e. the experience of 
living with follicular lymphoma under the watch and wait protocol. Nine individuals with a diagnosis 
of follicular lymphoma were recruited via consultant haematologists at a UK Regional Cancer Centre. 
Consultant Haematologists were asked to identify elgible patients from their caseloads. Inclusion 
criteria were stipulated as: adults (over the age of 18 years) who were currently not in active treatment 
for their lymphoma, i.e., were being maintained under the watch and wait protocol; who had never 
been diagnosed with another form of cancer; and who did not have comorbid severe mental health or 
neurocognitive difficulties that would inhibit their ability to participate. Haematologists identified 15 
eligible patients who were then approached by letter, signed by their consultant, inviting them to 
contact the researcher to arrange an interview at their convenience, either at the Cancer Centre or in
their own home. Four individuals did not respond to the invitation, and one individual was not able to 
participate due to his work schedule. Non-participants were two males and three females, aged 
between 32 and 74 years.  
Participants were five males and four females betwen the ages of 45 and 74 years (mean 62 
years). Time since diagnosis ranged from under one year to over seven years. All participants were 
white British; socio-economic status data were not collected. At the time of interview four described 
themselves as retired, three were in employment, and two identified themselves as being retired but 
working. Five participants had received no treatment, although two of these had received lymph node 
removal for testing. One person had received radiotherapy and three had had chemotherapy (one 
following therapeutic node removal). One participant had progressive disease but did not believe she 
would imminently be receiving treatment for this. Two suspected progression and were shortly to 
undergo investigations (see Table 1). The interviews lasted for an average of 70 minutes (range: 36 to 
157 minutes) and were conducted by EC either in the Cancer Centre or in participants’ own homes. 
Procedure and Data Collection 
Permission for the study was gained from National Health Service (NHS) Research and 
Development (R&D) management, the University of Edinburgh School of Health in Social Science 
Ethics Committee, site-specific R&D offices and theLothian NHS Research Ethics Service. An 
interview schedule was prepared to guide interviews, which consisted of general guiding questions 
such as ‘‘has anything changed since you were diagnosed with follicular lymphoma’’, ‘‘what has 
helped since being diagnosed?’’ and prompts to gain more depth of information when needed, such as, 
‘‘has anything changed in how you think of yourself since your diagnosis?’’. However, the aim was to 
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maintain a ‘conversational’ atmosphere and to allow the participant to direct the content of the 
interview, so an inductive process was adopted, using reflection (e.g. ‘‘you spoke about...’’) and 
probes (e.g. ‘‘can you tell me more about... ’’). Frequently, further details and clarification were asked 
for to elicit rich, insightful accounts. While time was allowed for each participant to express their own
narrative, the interview guide was developed iteratively, with participants being queried about 
elements of the experience that others had considered important (e.g. ‘some people have said... I 
wondered if you had experienced anything like that?’). This method was used to ensure that 
participants were able to tell their own story in their own words, without missing potentially important 
aspects of the experience that they may not have considered relevant without prompting. Interviews 
were recorded on a digital voice recorder and transcribed verbatim. 
Analysis 
An interpretative phenomenological analytic (IPA) approach was used in order to analyse 
transcripts for important themes for individual participants, and to further explore the similarities and 
differences between participants’ experiences. Thismethod has its origins in hermeneutics and 
phenomenology, taking the position that people interpret and actively make sense of their world rather 
than passively perceiving an objective reality. IPA is a ‘double hermeneutic’ process involving two 
stages of interpretation: the participant interprets their own experiences, and the researcher attempts to 
make their own sense of the participant’s interpretations (Smith and Osborn, 2003). As such, the 
interaction between the participant’s narrative andthe researcher’s interpretation is seen as 
fundamental to the aim of exploring the individual’s personal account of a phenomenon of interest: it 
is not an attempt to produce an objective record of the phenomenon. The intention in this study is to 
present themes in the form of insightful and transprent narrative accounts, using verbatim extracts to 
evidence the researchers’ interpretations (Smith, 2011). 
Each transcript was read several times in order to bec me familiar with the accounts and each 
was analysed individually before examining the transcripts for similarities and differences across 
participants. In each transcript, significant words, phrases or descriptions were highlighted, with 
emerging themes documented. Transcripts were coded according to emergent themes which were then 
clustered into one overarching theme of Adjustment, comprising three subthemes reflecting 
participants’ experiences of making sense of, coping with, and adapting to a diagnosis of follicular 
lymphoma: (1) Making sense of the condition in the context of existing and evolving knowledge and 
experiences; (2) Intrapersonal and interpersonal coping strategies; and (3) Incorporating the 
condition into the life narrative. Extracts are presented to illustrate key elements of each theme and to 
allow the reader to assess the author’s interpretations. All names are pseudonyms. The first author 
analysed all transcripts, with credibility checks carried out by three independent colleagues for a third
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of transcripts to ensure coding was appropriate, with 98% agreement. All three subthemes were 
present in the account of each participant. 
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Table 1. Participant background information  
Participant 
pseudonym Age Sex 
Years since 
diagnosis Treatment received to date 
Participants’ perception of lymphoma progression 
status at time of interview 
 ‘Cath’ 64 F 4 years Chemotherapy following diagnosis Possible progression (being investigated) 
 ‘Lynda’ 67 F 7 years Excision with chemotherapy following diagnosis and 
again one year ago 
No progression suspected  
 ‘Gary’ 65 M 6 years Participated in chemotherapy trial for two years 
following diagnosis 
No progression suspected  
 ‘Carol’ 71 F 3 years None No progression suspected  
 ‘Dave’ 65 M 4 years Radiotherapy to groin following diagnosis No progression suspected  
 ‘Alistair’ 45 M 3 years None  Possible progression (being investigated) 
 ‘Gordon’ 45 M 2 years None No progression suspected  
 ‘Maggie’ 62 F 4 years Abdominal radiotherapy following diagnosis Recent progression but decision to watch and 
wait 




Theme 1. Making sense of the condition in the context of existing and evolving knowledge and 
experiences  
All participants described having to reconcile the diagnosis of low-grade lymphoma with their 
assumption that cancer is a terrifying disease that must be fought to be survived. These were based on 
both personal experience and social constructs: 
Dave: Initially, all you hear is ‘cancer’. You don’t hear about the type of cancer, what the 
overall prognosis is, eh, you’re only hearing the word ‘cancer’, and you’re thinking back to, 
yeah, my father, or what I’ve read about it in the past. 
Maggie did not fully identify with being a cancer patient due to the absence of symptoms and indolent 
nature of the condition: 
Maggie: [at first] I really thought that I did have full blown cancer. You know, to me this isn’t 
full blown ... because it is so low grade ...  I do feel well and that’s the problem, I’ve never felt 
ill! 
Misunderstanding about the purpose of treatment occurs in the context of society’s discourse about 
cancer, as highlighted by Alistair: 
Alistair: I think it’s the fact that when people are diagnosed with something like this they want 
treated, and they want cured and they want to get on with their life, whereas if somebody tells 
them that, ‘actually, we’re not going to treat you right now’ ... that’s like, sort of ... difficult 
because everybody drums into you in the- all the publicity about cancer is you need to get it 
quick ... you need to treat it quick ... whereas lymphoma’s different. 
Several participants acknowledged that they were ‘lucky’ in comparison to those affected by more 
profoundly life altering conditions such as stroke r Alzheimer’s. However, there was a shared 
realisation that their diagnosis was fundamentally different to the experience of serious but curable 
conditions: 
Carol: I suppose it’s no different to a lot of things in life, but you’re not going to get past it, 
it’s going to at some point develop, because it’s not curable. Um, so it’s more concrete than 
some things that you come up against and you can del with them, you can put them behind. 
The impact of the diagnosis varied widely. The eldest participant was reassured by being told that the 
cancer was unlikely to be rapidly fatal and he could continue with his life with little change. However, 
for one of the youngest participants, the impact of diagnosis three years previously was profound: 
Alistair: It was the most bizarre day, my whole world just turned upside down in the space of 
about 10 seconds. 
This reflects the significance of life context in participants’ meaning-making. The importance of life
stage came up for a number of people. Most participants were over the age of 60 and felt that the 
condition was easier to understand and cope with than if they had been younger, reflecting Alistair’s 
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experience. Previous experiences of illness or adversity gave several participants a reference point and 
resources for coping, and for some the presence of omorbid illness or stressful life events made the 
lymphoma seem relatively insignificant: 
Gary: If you’ve got something else wrong with you, you don’t notice you’ve got it. I think 
maybe I would be more frightened if- I don’t know what other people, if they’ve got it, what 
they feel like ... because I’ve got all the other complications. 
There were more subtle effects on participants’ sense of identity and cohesion. These were complex 
ideas to grapple with: 
Carol: I must admit I fear becoming my illness... I don’t want to be identified only through the 
illness. I don’t know if I even understand that one myself... 
Alistair: There was a point where I felt that I was ctually no longer a part of the human race. 
You felt like you were up here, everybody else was going about their normal life, and you’re 
no longer part of that. 
Maggie: When I was out, and I know this sounds verystrange, I felt everybody was pointing 
the finger, I thought they knew that there was something wrong with me. 
Some felt conscious about how others might perceive them or react to the diagnosis, and there was a 
strong sense of not wanting to be pitied or offered empty reassurances: 
Lynda: ... it’s amazing how many people didn’t know. Didn’t know at all. Cause I didn’t tell 
everybody ... Not their business, its mine. And I di n’t want- I didn’t want sympathy ... And 
what really bothered me was this ‘oh you’ll be fine, I know you’ll be fine’. You know? You 
don’t know. 
An important but unanswerable question for participants was why they had developed the condition, 
particularly since most viewed themselves as having had a healthy lifestyle. Attributions included 
psychological stress, spiritual challenge (being ‘tested’), genetic (and therefore ‘inevitable’) causes, 
and a vague sense of fate or sacrifice: 
Alistair: It’s kind of weird, it was almost like, I don’t think it was being given to me for a 
reason, I’m not into all that kind of airy fairy stuff, but I have had a, um.. I’ve had a great life 
... Not a reason, but I think, if it was a choice between me and any of the members of my 
family I would take it, because I think I can deal with it better than they can. 
All participants’ accounts conveyed a sense of living with uncertainty and threat. Participants found 
that they could no longer interpret bodily sensations r changes, and often their consultants could not 
either. While some felt able to contact their consultant or GP to seek reassurance some lived with 
feelings of anxiety until their next appointment.  
Dave: I’ve put on about a stone since Christmas ... if  my weight hasn’t gone down [at my next 
appointment] there won’t be a problem at that check-up, but the next check up I go to, 
because I will have lost that stone ... they’ll say‘you’ve lost weight’ ... The last time that 
happened they sent me for a scan, because they’re unsure of whether it’s the cancer that’s 
causing a loss of weight , or whether it’s ... me on a diet, and they can’t trust me (laughs) so  
they send me for a scan. Which is great, cause it mans that I know for sure it’s not cancer. 
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Routine checkups were a universally emotive experience for participants, bringing both anxiety and 
relief:  
Carol: I forget that I’ve got anything wrong with me until it comes to just before the check-up 
and then you start to think, well, it’s routine but, you know, um ...  I’m always anxious to get 
the blood test over and done with and they say the magic words ‘your bloods are fine’. 
Participants spoke about the various ways they tried o source, understand and filter information to 
help them make sense of their situation. There was con ensus that the internet was likely to be 
unhelpful and frightening, however, some felt the ne d to supplement or confirm the information 
offered by their doctors. Participants mistrusted stati tics, feeling generalisations were unhelpful. 
Despite attempts to control the flow of information many found this was not always possible and at 
times were forced to confront uncomfortable issues: 
Cath: What [the pension advisor] was saying was ... if your life expectancy is shorter they can 
give you a bigger payout because they know you’re not going to live that long, relative, and at 
that time I hadn’t got all the information, so that, I found, was very difficult. 
In the absence of concrete information participants described making interpretations about their 
condition, often as a method of reassurance although it could also lead to frightening 
misunderstandings:  
Maggie: I had to go to [the chemotherapy ward]. I was probably putting two and two together 
but that’s where I saw [my consultant] … I thought, you’re going to tell me that I’m going to 
have to have chemo and I’m going to be shown round - that’s what I thought. 
Interviewer: What was that like? 
Maggie: Horrible, really bad.  
Interviewer: Did you mention that to him? That that’s what you’d thought? 
Maggie: No. 
Theme 2. Intrapersonal and interpersonal coping strategies 
Issues around information also came through in participants’ dialogue around coping with their 
lymphoma, with participants trying to arm themselves with sufficient knowledge to know how to cope, 
without becoming overwhelmed: 
Lynda: I just like to compile as much information as I possibly can, and make informed 
decisions. But everybody is different. 
Participants appeared to feel it was important to view the condition as a challenge rather than as a 
threat. However, elements of challenge, threat and loss were apparent in participants’ narratives: 
Alistair: It was this whole kind of rollercoaster. Which was interesting, it was definitely 
character building ... I don’t do unhappy, but this was a challenge for me, this was, and I think 
that was the biggest thing, I think I thought I’m never going to be that same person, it was 
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going to change me, I didn’t want to change because I lik d who I was, I liked that person 
who was always happy, and always cheery, and very rarely letting things get me down. 
While problem-focused coping styles are generally considered adaptive, one participant spoke of his 
initial attempts to ‘problem-solve’ his diagnosis, which on reflection he thought had been unhelpful 
and unhealthy:   
Alistair: My initial feelings when I was first diagnosed was one of sheer panic… and I did do 
some rather stupid things. I went down to see a specialist in London, who [is] part of this 
Oasis of Hope hospital in Mexico ... there’s so much pressure on you to try and dos mething. 
Interviewer: where did that pressure come from, do you think? 
Alistair: I think it came from myself, you know, I’m an engineer, that’s what I do, I fix things. 
Um, and I tried to fix myself. 
Robert, the eldest and most recently diagnosed participant, appeared to have found a way to be 
problem-focused while relying on the expertise of clini ians to be the problem-solvers: 
Robert: Oh, I watch myself like a hawk! Anything’s that’s untoward I’ll go and get it 
investigated, very rapid, because my philosophy now is, if there’s something wrong with you 
get it fixed as quick as possible, because the longer you delay the worse it can becom .  
The helplessness that is inherent in this life-long condition led many to use coping strategies involving 
distraction, distancing, avoidance and attempting to maintain a sense of normality: 
Gordon: I don’t know [how I deal with it]... just got to get on with it. I go out for a cycle or do 
my weights – take the aggression out ... I don’t know how you explain it, it can crack you up. 
I’m not going to crack up. It might eventually get on top of me, but- how I view it is, things 
that are causing you stress, get away from them. 
Most participants coped with the lack of control by firmly placing themselves in the hands of 
professionals: 
Dave: I can do a lot to a motorcycle or car or whatever, but when it comes to the modern cars 
and motorcycles, they’ve all got their on board computers and you need specialist equipment, 
and that’s sort of analogous to them across there. 
Maggie appeared to cope by not fully taking on board the incurable nature of the condition, 
acknowledging that she kept such thoughts from her mind, living, as she described it, in a protective 
‘bubble’. This led her to become acutely distressed when the ‘inevitable’ happened: 
Maggie: [I had thought] I’ve had the radiotherapy and now I’m getting better ... The minute 
she said [it had come back] that was it. The bubble was burst. It was very hard. ‘God, here we 
go again’, that was my words. You didn’t know what you were going to go and do or what you 
were going to get. 
Robert, on the other hand, acknowledged his condition while appearing able to put this advice from his 
consultant into practice: 
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Robert: He says, ‘you can go home and worry about it if you like, but it won’t make any 
difference’, so he says, more or less this is what he says anyway, ‘we’ll do what we can for 
you, when we need to do it, and in the meantime get on with your life’. That’s exactly what I 
did. 
A degree of acceptance is likely to be essential for coping with an incurable condition, and most 
participants made statements that indicated they recognised the potential risk of not confronting 
reality. Lynda spoke about monitoring herself for progression: 
Lynda: You have to be proactive. You don’t just say ‘if I don’t acknowledge it it’ll not happen’ 
you can’t be like that. I know a lot of people that are like that, ‘oh don’t talk about it’ or, ‘it’ll 
just settle – go away’. You have to investigate, but I’m not paranoid either! I’m not paranoid. 
I’m just, I’m sensibly cautious, I would say.  
Ultimately, participants had to somehow accept their powerlessness in the face of an incurable 
condition – most participants spoke of the importance of maintaining a hopeful and positive attitude. 
This included the use of humour and, for some, hope that a long-term condition such as this may one 
day have a cure: 
Alistair: ... the adverts on television are basically saying they will beat it – they’re confident 
they will beat it. So there is a confidence I think from the whole of society that we are in an 
era where we’re close ... which is good for people lik  myself - they might have something that 
I can take next year and it will go and that will be it.  
The social context emerged as central to coping with the condition. Participants spoke of the 
importance of support from friends, the difficulty of gaining support from family while feeling 
compelled to shield them from worrying information, a d the ambivalence towards gaining support 
from fellow patients due to the danger of ‘focusing’ on the condition and allowing it to take over their 
lives. The place of intimate partner relationships was a complex issue for this group – seen as 
particularly important but also uniquely fraught or nuanced. One aspect of this related to feeling 
‘alone’ without a partner, regardless of other support that was available. For the youngest two 
participants, both 45 years old, relationships had dissolved since diagnosis. It was common for 
participants to be fearful of becoming too dependent on their partners. However, for Carol, whose 
husband had previously been diagnosed with a lymphoa, the very closeness of the intimate partner 
relationship was a barrier: 
Carol: We don’t talk. I mean we talk, but we haven’t really gone very deeply into- ... we don’t 
talk deeply about it, it’s just one of these- I have friends [laughs]. I don’t know why, your 
partner just, I don’t know, sometimes to verbalise something makes it real. 
This stance reflected a broader sense of the need for self-reliance and self-preservation:  
Lynda: I’ve got two friends who’ve been diagnosed with cancer since I had mine, and what I 
did say to them was, ‘remember this is you, it’s got noth- it’s not your family’, because you 
find you spend time dealing with other people’s emotions. You know? And they’ve got no right 
to do that to you, because you’re dealing with something that is purely pertinent to you. 
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The relationship with the care team members had a special place in participants’ accounts of their 
experiences, with the long-term nature of their condition meaning that relationships with staff 
developed over time. While some experienced distresing investigative procedures or treatments, the 
overwhelming sense was that participants felt well cared for by their healthcare team. Potentially, 
however, this leaves patients (who will have lifelong involvement with the team) vulnerable to 
changes. For example, a sense of loss was expressed about a consultant who retired unexpectedly. 
Dave: You feel better cared for if it’s people that, or faces that you know. You feel as though 
you can speak to them a lot easier than a stranger. 
The importance of maintaining these relationships left some participants feeling uncomfortable about 
raising difficulties they had experienced as part of their healthcare: 
Cath: I did say to the [consultant], whoever it was, I aid, ‘you know, I don’t want any 
repercussions, because I’m going to be coming here for the next however long, a d I don’t 
want to be meeting this young man [a junior doctor] and him going ‘ha ha, that’s her that 
complained’. 
In terms of specialist psychological or emotional support, participants generally did not recognise the 
value of this, and were suspicious about what it might nvolve: 
Interviewer: When you say you’re not sure you have dealt with it, does that mean... that you 
would want to talk to somebody about it? 
Gordon: I don’t know how it would- to deal with it, you understand... sitting round holding 
hands has never- somebody might get comfort out of it but I cannae see myself- the point of it, 
eh.  
This made sense in the context of an underlying need for individuals to maintain their self-image of 
resilience and strength, and a reluctance to be defined by the condition: 
Alistair: ... the type of person I am I think I’ll be able to deal with it a lot better than some 
other people. Maybe not, maybe I’m not dealing with it at well. But I think some people 
would probably find it a lot harder 
Interviewer: What makes you think that? 
Alistair: I don’t know, just the type of person I am I think I do just tend to- I mean I’m not 
saying it’s easy but, er, if I was the type of person that constantly worried about things I think 
it would be quite difficult. I think it would be quite stressful. 
The need to conceal ‘weakness’ may negatively impact on the availability for support. This is 
illustrated by the case of Gary who suffers from chronic fatigue syndrome that has left him house-
bound and at times parasuicidal. The extract below relays his ‘bravado’ in communicating with his 
consultant at the time of his cancer diagnosis, an attitude which may potentially have concealed a need 
for psycho-social support to help him cope with his complex medical situation: 
Gary: I went to the hospital myself ... and my doctor says ‘is there somebody with you? I have 
to tell you, you’ve got lymphoma’. And I said ‘aye, right, fine, that’s too bad. What do I do 
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now?’ he says, ‘what do you mean?’ he says ‘all the rest of the patients are like- usually they 
break down  “you’ve got cancer”’. I says ‘no, you know, if I’ve got it I’ve got it’. 
Theme 3. Incorporating the condition into the life narrative  
The final theme relates to the sense participants were able to make of their condition, through 
understanding and coping with it, placing it in thebroader narratives of their lives. There was an 
overall sense of heightened awareness of the fragility and preciousness of life, and a desire to live life 
to the full: 
Lynda: It’s made me more aware of doing as much as I c n. Enjoying my life as much as I 
can. Getting as many experiences in my life as I can ... I’m very grateful of the fact that I’ve 
survived, and I’m very grateful to be alive, every day ... I think that cancer was a wake- up 
call. Made me realise that, you know, life’s precious. 
Dave: Since I was diagnosed with this I’ve said ‘right, hell I’m doing this’. So we’ve been to 
India on bikes, we’ve been to Poland, northern Spain on motorcycles, this year we’re going to 
do Russia ... But it’s, it’s things like that where you think- I suppose it’s a bucket list. It’s 
things that, you say ‘ach, I’ll do that someday’ but someday never comes, unless you actually 
decide ‘right, I’m doing that!’. 
Several participants felt frustrated by people who did not appear to appreciate the value of life:   
Interviewer: Do you think anything’s changed since you’ve had your diagnosis? 
Cath: I’m a little bit more intolerant of people. Particularly in the medical aspect, when they 
make fusses about stuff which really ... I’ve got to work hard at being as sympathetic to 
certain things now. Somebody that smokes, non-stop, that is worried because they’ve got to go 
and have a chest x-ray in case they’ve got something nasty ... and I’m like, you know, some 
people want to live. 
For many participants there was increased salience of values and priorities: 
Alistair: I’ve always been a very family-orientated person, but I do definitely feel that you kind 
of hang on to- you don’t cling on to people, but I think you appreciate the peopl that are 
close in your life…   
Robert, who had prepared for and was thoroughly enjoyi g his retirement, appeared to have 
established his values prior to his diagnosis and seemed to find the whole experience less challenging 
than other participants: 
Robert: No. Nothing’s changed. It’s just something that they’ve told me I’ve got, and I’m 
dealing with it. It hasn’t had any effect on my life at all. None whatsoever. 
However, despite the new awareness of their values and priorities, several participants spoke of the 
decreased opportunities they perceived as a result of their diagnoses. For example, Cath felt unable to 
travel to exotic locations because of the poorer medical care. Alistair felt that his diagnosis limited his 
chances of finding a partner: 
Alistair: I try to focus on the present [now] but I used to always plan for the future. I used to 
always have my great ideas and what it was going to be like, where I was going to be in the 
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future, but I don’t think you can focus on that toomuch now, because ... I’m a potential time 
bomb. 
Unfortunately, for Gary, life felt limited by being housebound and reliant on people who were not 
prepared to meet his needs. He was therefore perhaps prevented from having the revelatory 
experiences that others reported: 
Interviewer: Do you think anything’s changed for you since you’ve found out that you have 
cancer? 
Gary: Not really, I mean the wife says she’s retired now and she’ll not be in so you have to 
look after yourself, and I can’t ... I never thought I was going to be like this when I retired. 
[Before becoming ill with ME I had] never been off my work. 
With their experiences of personal growth and challenge, participants felt that they had developed a 
healthier sense of perspective on life: 
Carol: There’s a lot of things in life that are icing on the cake, and you don’t need to bother 
about them ... I think all this squabbling between r latives and sisters and things, they’re not a 
priority either. I don’t get involved if I don’t need to. You just think ‘what are they bothering 
about?’. 
Ultimately, there was awareness among participants that whatever direction their lives would take, the
cancer would be there, and the sense of underlying threat would remain: 
Carol: It’s not something that you can deal with and put away because it stays there, the 
illness itself, you just don’t know whether it’s going to develop. 
Discussion 
The aim of this study was to explore patients’ experiences of living with a diagnosis of 
follicular lymphoma while not receiving treatment. An overarching theme of adjustment reflected 
participants’ attempts to make sense of the condition n the context of existing and evolving 
knowledge and experiences relating to cancer in general and this particular diagnosis, intrapersonal 
and interpersonal strategies used to cope with the condition, and incorporation of the condition into the 
life narrative. 
Faulkner and Maguire (1994) suggest that psychological adjustment to cancer is associated 
with six ‘hurdles’ for the patient: managing uncertain y about the future, searching for meaning, 
dealing with a degree of loss, having a need for openness, and the needs for emotional and medical 
support. For this group of patients uncertainty related primarily to the uncertain progression of the 
illness, not whether it would progress. This led to a sense of looming threat for some, although life 
stage and previous and current life events affected participants’ illness experiences. 
Of the six ‘hurdles’, the need for emotional support was perhaps the most complicated for 
these participants: most had experienced some sort of barrier to discussing their feelings, either with 
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those closest to them (especially partners) or withcl nicians. This was most often related to the 
importance of self- and others’ perceptions of their ab lity to cope. Participants were hesitant about the 
possibility of receiving specialist support from NHS or Third Sector agencies. There were also mixed 
feelings relating to accessing peer support. Interes ingly, those who appeared to feel the least 
distressed by their lymphoma diagnosis were more cuious about meeting others with the same 
diagnosis, while participants who were struggling more were reluctant to reveal their concerns or 
expose themselves to this potential source of worrying information regarding their condition. 
The search for meaning was reflected in all participants having attempted to reconcile their 
preconceptions about cancer as an immediately life-threatening condition that must be fought, with the 
information they had accrued relating to indolent lymphoma. For some participants an illness that is 
treatable but not curable continued to be confusing. This appeared to be in part due to participants’ 
attempts to maintain a sense of normality by allowing l ttle space in their thoughts for their diagnosis. 
Most also made attempts to understand what had caused their condition. 
For many participants there was a determination to remain ‘positive’ and maintain their self-
image of being defiant and able to cope. Coping technically refers to actions that function to reduce 
the stressfulness of a challenging situation, however, the term is generally used more loosely to refer 
to any responses to a challenge. Coping can be an autom tic response or a conscious, considered 
strategy, and an individual’s ways of coping with illness reflect their previous experiences of coping 
with adversity (Salmon, 2000).  Coping strategies have been classified as either problem- or emotion 
focused (Lazarus and Folkman, 1984): Problem-focused coping involves behavioural or cognitive 
attempts to meet a challenge. The latter may involve, for example, coping ‘self-talk’ and for 
individuals with follicular lymphoma this may be a more effective strategy, considering that there is 
little the individual can do behaviourally to influence their illness. As discovered by ‘Alistair’, fruitless 
attempts to do so may result in more cost than benefit.  
Emotion-focused coping refers to attempts to manage the motions, including avoidance, 
distraction and a range of defensive strategies. Avoidant strategies may be a helpful short-term 
approach in certain situations, such as during medical procedures (Salmon, 2000) and there is the 
potential for adaptive longer-term strategies, such as ‘downward comparison’ (Helgeson and Taylor, 
1993) which a number of participants in this study sed, helping them to view their own situation 
favourably in relation to other imagined illness. The risk of this strategy was that participants appered 
to view themselves as having an illness that is not as deserving of sympathy or support as more 
aggressive forms of cancer.  
‘Emotional support’ refers to the availability of people in whom one can confide feelings or 
difficulties. This relies on the quality, not just the existence, of relationships, requiring supportive 
others who can facilitate disclosure and are able to isten without needing to be protected themselves 
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(Salmon, 2000). Several participants seemed to perceiv  emotional support to be provided in a unique 
way by an intimate partner; however, for a variety of reasons most participants had not felt that this 
support was available to them. This may represent unique characteristics of the study sample, where 
several participants had recently separated from partners and several were in relationships that they 
described as being difficult.  
In the present study ‘Maggie’ referred to having been ‘in denial’ and of her ‘bubble bursting’ 
leading to her feeling ‘devastated’ when she was confronted with the reality of disease progression. 
However, the signs of this were very subtle due to her cheerful demeanour and her self-perception that 
her coping strategy was a healthy determination to ‘stay positive’. Denial is conceptualised as a 
maladaptive response in which unconscious attempts are made to protect oneself against emotional 
threat. This may be revealed when patients appear to fo get or misunderstand information relating to 
their illness (Salmon, 2000). ‘Maggie’s’ situation suggests that subtle forms of denial may easily be 
missed by clinicians. Considering this, it should be noted that avoidance of thoughts related to a 
stressor do not, according to Salmon (2000), represnt a coping strategy in itself but rather an aspect of 
the experience of distress. That is, avoidant coping does not cause distress – it is distress.  
 ‘Gary’ spoke of the distress he felt through being dependent on others due to his comorbid 
ME, feeling his emotional and practical support needs were not recognised. On the other hand he 
spoke with some bravado about the nonchalant way he had responded when faced with his lymphoma 
diagnosis. ‘Reaction formation’, another form of deensive emotion-focused coping, occurs when an 
individual emphasises the opposite to how he or she actually feels (Salmon, 2000). This reaction in 
‘Gary’ may mask his distress from clinicians who would otherwise be in a position to suggest avenues 
for support. 
‘Rationalisation’ takes place when patients interprt ambiguous information favourably in 
attempts to provide a logical explanation for events that prevent them having to confront possible 
threats. This occurred, for example, when participants interpreted postponements to appointments as a 
sign that they were better than expected. It may be that patients with follicular lymphoma have a 
tendency to use this approach because of the need to manage anxiety in a condition with vague 
symptoms. 
‘Displacement’ was evident in the account of ‘Lynda’ who reported enduring anger towards a 
GP who had phoned her to wish her luck with an appointment before she knew that she had cancer, 
forcing her to realise that this was a possibility. While she denied feeling angry about any other aspect 
of her experiences she was unwilling to relinquish the anger she felt towards this individual. She was, 
however, reluctant to confront the GP out of respect for her professional status. The urge to be a 
‘good’ patient is recognised as a response in patients who find themselves in positions of 
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powerlessness (Salmon, 2000). ‘Cath’ – herself in the nursing profession – had expressed reluctance to 
complain about what she saw as substandard treatment from a junior doctor for fear of repercussions.  
Most participants had experienced a heightened awareness of the fragility and preciousness of 
life, giving them a ‘healthier’ sense of perspective and spurring them to prioritise and live their lives to 
the full. However, for participants living with concurrent social or medical stressors these potential 
benefits appeared to be overshadowed and they felt their options for ‘valued living’ were limited 
despite not suffering symptoms from their FL. 
Clinical Implications 
Results pooled from multiple studies suggest that approximately 40% of cancer patients report 
significant distress (Carlson et al., 2012). Clinical practice guidelines in oncology distress 
management (National Comprehensive Cancer Network, 2012) recommend that patients are routinely 
screened for distress, and referrals made or support offe ed as appropriate. Psycho-oncology services 
can play a key role in facilitating and supporting the use of psychosocial screening procedures, 
however, all multidisciplinary team members must be prepared to play a part in implementing these 
best practices.  
Attempts should be made to identify the most personally threatening aspect of their situation 
for each patient (White, 2001). The assessment of psychosocial problems requires clinicians to take 
account of the unique aspects of each patient’s experiences and participant accounts reinforce the need
for holistic care.  Patients can be helped to disclose emotional material by allowing them time to 
express their feelings, empathising, using open questions, asking about psychosocial issues, seeking 
clarification of patients’ psychosocial comments or emotional non-verbal communications, 
summarising what they have said and offering ‘educated guesses’ as to how they might be feeling 
(Maguire et al., 1996). It is hoped that this research can contribute towards the educated guesses that 
clinicians can offer.  
Salmon (2000) suggests that patients do not generally see themselves as ‘coping with a 
challenge’ but as ‘responding to a situation’, and that simply introducing the concept of coping can 
help patients to think differently about their situation and develop more adaptive coping responses. 
While there is little, behaviourally, that patients can do to influence the progression of their illness, it 
may be helpful to encourage patients to behave in ways that help them cope with the emotional impact 
of having this incurable condition, for example, maint ining a healthy lifestyle, maintaining social 
networks, engaging with their values, and being open to talking about their experiences. 
According to theories of stress-coping, the degree to which challenging events are experienced 
as being stressful depends on intervening psychological and social processes of appraisal, ways of 
coping and social support (Lazarus and Folkman, 1984). These characteristics of coping suggest that, 
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while patients cannot and should not necessarily be protected from the ‘challenge’ of their diagnosis, 
they can be offered some protection from stress by modifying the intervening factors (Salmon, 2000). 
Helping patients to appraise their condition as a challenge rather than a threat may help, as well as 
ensuring psychosocial factors are considered and supported by all members of the healthcare team.  
The importance of the patient-doctor relationship may leave patients vulnerable to feeling a 
responsibility to maintain it at personal cost, and to feeling a sense of loss if it terminates for reasons 
outside their control. The healthcare team is not oly involved in healthcare tasks with each patient – 
they are in a relationship that is a vital part of patients’ coping. Teams must be aware and give 
attention to this important aspect of care for patients with long term conditions. Participants’ accounts 
suggest that as much continuity of care as possible hould be offered patients, who should receive 
clear and timely information about any changes that are likely to occur in these important 
relationships.  
Limitations and Future Directions 
In the present study the sample consisted of British Caucasian people. It is possible that some 
of the findings relating to interpersonal support and the importance of appearing to cope has cultural 
elements. It would therefore be relevant to repeat the research with culturally different patients with 
follicular lymphoma. The small sample size used in qualitative research does not lend itself to making 
generalisations, however, the depth and richness of data that is permitted by this approach allows 
aspects of the patient’s experience to be discovered which may otherwise remain hidden. Research 
focusing more specifically on elements of the patient experience highlighted in this research would 
allow a more thorough understanding, for example: th  impact of life stage and life stressors on 
patients’ appraisals and coping ; and patients’ and their significant others’ perceptions of changing 
roles and relationship dynamics when an individual develops a low-grade cancer. The present study 
suggests directions for developing psycho-educationl materials and psychosocial support provision 
for patients living with this type of malignancy. These should be developed, piloted and evaluated 
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Appendix A: Quality Assessment Tool for Qualitative Papers (adapted from Seymour et al., 2010) 
 
Rating Score Conversion 
Good 3 points 
Fair 2 points 
Poor 1 point 
Very poor 0 points 
 
1. Abstract and title: Did they provide a clear description of the study? 
          
Good  Structured abstract with full information and clear title.  
Fair  Fair abstract with most of the information.  
Poor  Inadequate abstract. 
Very poor  No abstract.  
 
2. Introduction and aims: Was there a good background and clear statement of the aims of the research? 
 
Good  Good full but concise background to discussion/study containing up-to date literature review and 
highlighting gaps in knowledge. Clear statement of aim AND objectives including research questions. 
Fair  Some background and literature review. Research questions outlined. 
Poor  Some background but no aim/objectives/questions, OR Aims/objectives but inadequate background. 
Very Poor No mention of aims/objectives. No background or litera ure review. 
 
3. Method and data collection: Is the method appropriate and clearly explained? 
 
Good Method is appropriate and described clearly (e.g. interview guide included). Clear details of the data 
collection and recording. 
Fair Method appropriate, description could be better. Data collection described. 
Poor  Questionable whether method is appropriate. Method described inadequately. Little description of data 
collection. 
Very Poor  No mention of method, AND/OR method inappropriate, AND/OR no details of data collection. 
 
4. Sampling: Was the sampling strategy appropriate to address the aims? 
 
Good Details (age/gender/race/context) of who was studied and how they were recruited. Why this group was 
targeted. The sample size was justified for the study. Response rates shown and explained. 
Fair Sample size justified. Most information given, but some missing.  
Poor  Sampling mentioned but few descriptive details.  
Very Poor No details of sample.  
 
5. Data analysis: Was the description of the data an lysis sufficiently rigorous? 
 
Good  Clear description of how analysis was done. Description of how themes derived/respondent validation 
or triangulation. 
Fair  Descriptive discussion of analysis.  
Poor  Minimal details about analysis. 
Very Poor No discussion of analysis. 
 
6. Ethics, bias and rigour: Have ethical issues been addressed, and what has necessary ethical approval 
gained? Has the relationship between researchers and participants been adequately considered? 
 
Good  Ethics: Where necessary issues of confidentiality, sensitivity, and consent were addressed. Bias: 
Researcher was reflexive and/or aware of own bias. Rigour: Attempts made to ensure the rigour of the 
research 
Fair  Lip service was paid to above (i.e. these issues were acknowledged).  
Poor  Brief mention of issues. At least, evidence that ethical approval has been sought.  






7. Results: Is there a clear statement of the findings? 
 
Good  Findings explicit, easy to understand, and in logical progression. Tables, if present, are explained i 
text. Discussion of results relate directly to aims. Sufficient data are presented to support findings. 
Fair  Findings mentioned but more explanation could be giv n. Data presented in discussion relate directly to 
results. 
Poor  Findings presented haphazardly, not explained, and do not progress logically from results. Qualitative 
data presented with stats or percentages with only limited suggestion that results were used within a 
qualitative paradigm. 
Very Poor Findings not mentioned or do not relate to aims. Qualitative data presented as stats or percentages only 
(e.g. 4/8, 50% participants said…). 
 
8. Transferability or generalisability: Are the findings of this study transferable (generalisability) to a 
wider population? 
 
Good  Context and setting of the study is described sufficiently to allow comparison with other contexts and 
settings, plus high score in Question 4 (sampling). 
Fair  Some context and setting described, but more needed to r plicate or compare the study with others, 
PLUS fair score or higher in Question 4. 
Poor  Minimal description of context/setting. 
Very Poor No description of context/setting. 
 
9. Implications and usefulness: How important are these findings to policy and practice? 
 
Good  Contributes something new and/or different in terms of understanding/insight or perspective. Suggests 
ideas for further research. Suggests implications fr policy and/or practice. 
Fair  Two of the above.  
Poor  Only one of the above.  
Very Poor  None of the above. 
 
10. Limitations: Are the limitations of the study discussed? 
 
Good  Clear description of limitations with critical analysis of impact.  
Fair  Descriptive list of study limitations. 
Poor  Minimal details of study limitations.  
Very Poor No mention of study limitations.  
 
11. Quotes: Are direct quotes of participants used to illustrate qualitative findings? 
 
Good  Directs quotes used with full explanation of context and meaning and who they were made by (e.g. 
male, carrier). Quotes linked back to results to clearly illustrate points. 
Fair  Direct quotes used with some explanation of meaning.  
Poor  Minimal quotes used with little or no explanation  
Very Poor No quotes used. 
 
12. Relevance to Systematic Review research question. 
 
Good  Study explicitly based on a type of haematological cancer that is incurable (myeloma, chronic 
leukaemias, indolent lymphomas – see below)  
Fair  Study based on a mixed sample, but sample is clearly defined and sufficiently balanced  
Poor  Sample is unclearly defined, but sufficient evidence in text of adequate representation of people with
incurable condition 
Very Poor  Insufficient information, although is not explicitly based on a sample of people with aggressive/high 
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Abstract and title 3 3 3 3 3 3 3 3 
Introduction and aims 2 2 2 3 2 3 3 3 
Method and data 
collection 
3 2 2 3 3 3 3 3 
Sampling 3 2 2 2 2 3 3 3 
Data analysis 3 3 2 3 3 3 3 3 
Ethics, bias and rigour 2 2 3 3 3 2 2 2 
Clarity of results 3 3 3 3 3 3 3 3 
Transferability or 
generalisability 
3 2 2 3 2 3 3 3 
Implications and 
usefulness 
3 2 2 3 2 3 3 2 
Discussion of limitations  1 3 1 3 1 3 3 2 
Quality of quotes used 3 3 3 2 2 2 2 3 
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question 
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Appendix D: Participant Information Sheet 
 
 
Version 2, October, 2012 
Participant Information Sheet 
The Experience of ‘Watch and Wait’ for People with Follicular Lymphoma:  
A Qualitative Investigation 
What is the purpose of the study? 
The aim of this study is to find out more about 
what it is like for people to be kept under 
observation for their follicular lymphoma, 
without currently receiving treatment. This is 
often called ‘watch and wait’ or ‘watchful 
waiting’. We hope this will help us develop ways 
to inform and support patients through this 
experience. 
Why have I been asked to take part? 
You have been asked to take part because you 
have been diagnosed with follicular lymphoma 
and are currently on ‘watch and wait’. 
Do I have to take part? 
No, it is up to you to decide whether or not to 
take part. You will be phoned by the researcher 
so you can ask questions and discuss the 
possibility of taking part, only if you have agreed 
to be contacted. If you do decide to take part you 
will be asked to sign a consent form when you 
come for interview, this will also be signed by the 
researcher who is running this study.  You will 
still be free to withdraw at any time and without 
giving a reason.  Deciding not to take part or 
withdrawing from the study will not affect the 
healthcare that you receive. This information 
sheet is yours to keep. 
What will happen if I take part? 
You will be asked to take part in one interview of 
about one hour in length with the researcher, 
who is a member of the clinical psychology team 
in the XXX Cancer Centre. The interview will be 
a discussion about your own individual 
experiences of what it is like being on watch and 
wait. The interview will be arranged to take 
place at the XXX Hospital at a time that is 
 What are the possible benefits of taking part? 
By taking part you will help us to understand 
what it is like for our patients to be on watch and 
wait and so help us develop services for people 
who are in a similar situation to you. There is 
evidence that some people find it helpful to talk 
about their experiences, which is what is 
involved in taking part in this study. We would 
also be able to guide you in accessing additional 
support if you need it, although this guidance 
and support would be available whether you take 
part or not. 
What are the possible disadvantages and risks 
of taking part? 
Taking part in the study would mean you having 
a discussion with the researcher, which will take 
about an hour. This interview will be recorded so 
the researcher can listen to it again and draw out 
important themes. It is not thought that there are 
many disadvantages of taking part; however, it is 
possible that some upsetting issues might come 
up in the discussion. As a psychologist the 
researcher is very used to helping people talk 
about difficult issues and managing the feelings 
that arise. If it seemed that you may benefit from 
additional support from the clinical psychology 
service, and you would like to receive this, it can
be arranged. You can also be informed of other 
ways to receive support. 
What happens when the study is finished? 
Interview recordings will be typed up as 
transcripts and the recordings destroyed. Any 
details that could be used to identify you will be 
removed from the transcripts. Anonymised data 
from the study will be stored securely for a 
period of ten years to allow for review of the 
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convenient to you. If you are not able to attend 
the hospital for an interview we can try to 
arrange to interview you at your home or at XXX 
Hospital in XXX . 
Will my taking part in the study be kept 
confidential? 
All the information collected during the course of 
the research will be kept confidential and there 
are strict laws which safeguard your privacy at 
every stage. Your name will be removed from the 
data so that you cannot be recognised from it. 
What will happen to the results of the study? 
The study will be written up as a doctoral thesis 
in part fulfilment of the researcher’s Doctorate 
in Clinical Psychology. The intention is also to 
publish the findings in a scientific peer reviewed 
journal. The results may also be presented to 
colleagues in cancer services and at other 
events, such as conferences. There will never be 
information about you included in documents or 
presentations which would allow you to be 
identified. All participants will be sent a 
summary of the findings if they have indicated 
that they would like to receive this. 
 
data. 
Who is organising the research and why? 
This study has been organised by Ellie Caldwell, 
Specialist Psychological Practitioner, under the 
supervision of Dr XXX, Clinical Psychologist, 
based at the University of Edinburgh, and Dr 
XXX, Clinical Psychologist, based in the Clinical 
Psychology Department at the XXX Cancer 
Centre. Consultant Haematologists and 
Oncologists at the XXX Cancer Centre are also 
helping with this research. The research is being 
organised to help the XXX Cancer Centre 
develop better ways to inform and support 
patients with follicular lymphoma who are being 
kept under observation without currently 
receiving treatment (known as watch and wait). 
Who has reviewed the study?  
The study proposal has been reviewed by both 
clinical and academic supervisors, and 
independently by the Clinical Psychology 
programme team at the University of Edinburgh. 
A favourable ethical opinion has been obtained 
from XXX REC, the University of Edinburgh, and 
a representative from NHS XXX Research and 
Development.  NHS management approval has 
also been obtained, 
Thank you for taking the time to read this information 
 
If you have any further questions about the study please contact Ellie Caldwell via the Clinical Psychology 
Department secretary, XXX. 
If you have any concerns about the study you can, in the first instance, discuss these with Dr XXX by contacting 
her via XXX. 
 




If you would like to talk to a person about this research who is independent of the study, you may contact XXX, 
email: XXX. XXX is a researcher in the Department of Clinical Psychology who is not involved with this particular 
study. 
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